カテゴリー： Market Monitor Global, 世界, 医療/バイオ

レストレスレッグス症候群治療の世界市場見通し2023年-2029年

◆英語タイトル：Restless Legs Syndrome Treatment Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8632 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：68 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Restless Legs Syndrome Treatment Market 調査レポートは次の情報を含め、グローバルにおけるのレストレスレッグス症候群治療市場規模と予測を収録しています。・世界のレストレスレッグス症候群治療市場：売上、2018年-2023年、2024年-2029年
・世界のレストレスレッグス症候群治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のレストレスレッグス症候群治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「一次性レストレスレッグス症候群」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

レストレスレッグス症候群治療のグローバル主要企業は、Boehringer Ingelheim、 Jazz Pharmaceuticals、 GSK Plc、 UCB、 Sun Pharmaceutical、 Arbor Pharmaceuticals、 Astellas Pharma、 Noctrix Health、 Zhejiang Huahai、 Psychocare Health、 Axxonis Pharma、 Jazz Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、レストレスレッグス症候群治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のレストレスレッグス症候群治療市場：タイプ別、2018年-2023年、2024年-2029年
世界のレストレスレッグス症候群治療市場：タイプ別市場シェア、2022年
・一次性レストレスレッグス症候群、二次性レストレスレッグス症候群

世界のレストレスレッグス症候群治療市場：用途別、2018年-2023年、2024年-2029年
世界のレストレスレッグス症候群治療市場：用途別市場シェア、2022年
・病院、小売薬局、その他

世界のレストレスレッグス症候群治療市場：地域・国別、2018年-2023年、2024年-2029年
世界のレストレスレッグス症候群治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるレストレスレッグス症候群治療のグローバル売上、2018年-2023年
・主要企業におけるレストレスレッグス症候群治療のグローバル売上シェア、2022年
・主要企業におけるレストレスレッグス症候群治療のグローバル販売量、2018年-2023年
・主要企業におけるレストレスレッグス症候群治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Boehringer Ingelheim、 Jazz Pharmaceuticals、 GSK Plc、 UCB、 Sun Pharmaceutical、 Arbor Pharmaceuticals、 Astellas Pharma、 Noctrix Health、 Zhejiang Huahai、 Psychocare Health、 Axxonis Pharma、 Jazz Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
レストレスレッグス症候群治療市場の定義
市場セグメント
世界のレストレスレッグス症候群治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のレストレスレッグス症候群治療市場規模
世界のレストレスレッグス症候群治療市場規模：2022年 VS 2029年
世界のレストレスレッグス症候群治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのレストレスレッグス症候群治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のレストレスレッグス症候群治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：一次性レストレスレッグス症候群、二次性レストレスレッグス症候群
レストレスレッグス症候群治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、小売薬局、その他
レストレスレッグス症候群治療の用途別グローバル売上・予測

・地域別市場分析
地域別レストレスレッグス症候群治療市場規模 2022年と2029年
地域別レストレスレッグス症候群治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Boehringer Ingelheim、 Jazz Pharmaceuticals、 GSK Plc、 UCB、 Sun Pharmaceutical、 Arbor Pharmaceuticals、 Astellas Pharma、 Noctrix Health、 Zhejiang Huahai、 Psychocare Health、 Axxonis Pharma、 Jazz Pharmaceuticals
...

This report aims to provide a comprehensive presentation of the global market for Restless Legs Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Restless Legs Syndrome Treatment. This report contains market size and forecasts of Restless Legs Syndrome Treatment in global, including the following market information:
Global Restless Legs Syndrome Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Restless Legs Syndrome Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Primary Restless Legs Syndrome Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Restless Legs Syndrome Treatment include Boehringer Ingelheim, Jazz Pharmaceuticals, GSK Plc, UCB, Sun Pharmaceutical, Arbor Pharmaceuticals, Astellas Pharma, Noctrix Health and Zhejiang Huahai, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Restless Legs Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Restless Legs Syndrome Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Restless Legs Syndrome Treatment Market Segment Percentages, by Type, 2022 (%)
Primary Restless Legs Syndrome
Secondary Restless Legs Syndrome
Global Restless Legs Syndrome Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Restless Legs Syndrome Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Restless Legs Syndrome Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Restless Legs Syndrome Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Restless Legs Syndrome Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Restless Legs Syndrome Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Jazz Pharmaceuticals
GSK Plc
UCB
Sun Pharmaceutical
Arbor Pharmaceuticals
Astellas Pharma
Noctrix Health
Zhejiang Huahai
Psychocare Health
Axxonis Pharma
Jazz Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Restless Legs Syndrome Treatment, market overview.
Chapter 2: Global Restless Legs Syndrome Treatment market size in revenue.
Chapter 3: Detailed analysis of Restless Legs Syndrome Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Restless Legs Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Restless Legs Syndrome Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Restless Legs Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Restless Legs Syndrome Treatment Overall Market Size
2.1 Global Restless Legs Syndrome Treatment Market Size: 2022 VS 2029
2.2 Global Restless Legs Syndrome Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Restless Legs Syndrome Treatment Players in Global Market
3.2 Top Global Restless Legs Syndrome Treatment Companies Ranked by Revenue
3.3 Global Restless Legs Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Restless Legs Syndrome Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Restless Legs Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Restless Legs Syndrome Treatment Players in Global Market
3.6.1 List of Global Tier 1 Restless Legs Syndrome Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Restless Legs Syndrome Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Restless Legs Syndrome Treatment Market Size Markets, 2022 & 2029
4.1.2 Primary Restless Legs Syndrome
4.1.3 Secondary Restless Legs Syndrome
4.2 By Type – Global Restless Legs Syndrome Treatment Revenue & Forecasts
4.2.1 By Type – Global Restless Legs Syndrome Treatment Revenue, 2018-2023
4.2.2 By Type – Global Restless Legs Syndrome Treatment Revenue, 2024-2029
4.2.3 By Type – Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Restless Legs Syndrome Treatment Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Restless Legs Syndrome Treatment Revenue & Forecasts
5.2.1 By Application – Global Restless Legs Syndrome Treatment Revenue, 2018-2023
5.2.2 By Application – Global Restless Legs Syndrome Treatment Revenue, 2024-2029
5.2.3 By Application – Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Restless Legs Syndrome Treatment Market Size, 2022 & 2029
6.2 By Region – Global Restless Legs Syndrome Treatment Revenue & Forecasts
6.2.1 By Region – Global Restless Legs Syndrome Treatment Revenue, 2018-2023
6.2.2 By Region – Global Restless Legs Syndrome Treatment Revenue, 2024-2029
6.2.3 By Region – Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Restless Legs Syndrome Treatment Revenue, 2018-2029
6.3.2 US Restless Legs Syndrome Treatment Market Size, 2018-2029
6.3.3 Canada Restless Legs Syndrome Treatment Market Size, 2018-2029
6.3.4 Mexico Restless Legs Syndrome Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Restless Legs Syndrome Treatment Revenue, 2018-2029
6.4.2 Germany Restless Legs Syndrome Treatment Market Size, 2018-2029
6.4.3 France Restless Legs Syndrome Treatment Market Size, 2018-2029
6.4.4 U.K. Restless Legs Syndrome Treatment Market Size, 2018-2029
6.4.5 Italy Restless Legs Syndrome Treatment Market Size, 2018-2029
6.4.6 Russia Restless Legs Syndrome Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Restless Legs Syndrome Treatment Market Size, 2018-2029
6.4.8 Benelux Restless Legs Syndrome Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Restless Legs Syndrome Treatment Revenue, 2018-2029
6.5.2 China Restless Legs Syndrome Treatment Market Size, 2018-2029
6.5.3 Japan Restless Legs Syndrome Treatment Market Size, 2018-2029
6.5.4 South Korea Restless Legs Syndrome Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Restless Legs Syndrome Treatment Market Size, 2018-2029
6.5.6 India Restless Legs Syndrome Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Restless Legs Syndrome Treatment Revenue, 2018-2029
6.6.2 Brazil Restless Legs Syndrome Treatment Market Size, 2018-2029
6.6.3 Argentina Restless Legs Syndrome Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Restless Legs Syndrome Treatment Revenue, 2018-2029
6.7.2 Turkey Restless Legs Syndrome Treatment Market Size, 2018-2029
6.7.3 Israel Restless Legs Syndrome Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Restless Legs Syndrome Treatment Market Size, 2018-2029
6.7.5 UAE Restless Legs Syndrome Treatment Market Size, 2018-2029
7 Restless Legs Syndrome Treatment Companies Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Restless Legs Syndrome Treatment Major Product Offerings
7.1.4 Boehringer Ingelheim Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.1.5 Boehringer Ingelheim Key News & Latest Developments
7.2 Jazz Pharmaceuticals
7.2.1 Jazz Pharmaceuticals Company Summary
7.2.2 Jazz Pharmaceuticals Business Overview
7.2.3 Jazz Pharmaceuticals Restless Legs Syndrome Treatment Major Product Offerings
7.2.4 Jazz Pharmaceuticals Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.2.5 Jazz Pharmaceuticals Key News & Latest Developments
7.3 GSK Plc
7.3.1 GSK Plc Company Summary
7.3.2 GSK Plc Business Overview
7.3.3 GSK Plc Restless Legs Syndrome Treatment Major Product Offerings
7.3.4 GSK Plc Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.3.5 GSK Plc Key News & Latest Developments
7.4 UCB
7.4.1 UCB Company Summary
7.4.2 UCB Business Overview
7.4.3 UCB Restless Legs Syndrome Treatment Major Product Offerings
7.4.4 UCB Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.4.5 UCB Key News & Latest Developments
7.5 Sun Pharmaceutical
7.5.1 Sun Pharmaceutical Company Summary
7.5.2 Sun Pharmaceutical Business Overview
7.5.3 Sun Pharmaceutical Restless Legs Syndrome Treatment Major Product Offerings
7.5.4 Sun Pharmaceutical Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.5.5 Sun Pharmaceutical Key News & Latest Developments
7.6 Arbor Pharmaceuticals
7.6.1 Arbor Pharmaceuticals Company Summary
7.6.2 Arbor Pharmaceuticals Business Overview
7.6.3 Arbor Pharmaceuticals Restless Legs Syndrome Treatment Major Product Offerings
7.6.4 Arbor Pharmaceuticals Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.6.5 Arbor Pharmaceuticals Key News & Latest Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Company Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Restless Legs Syndrome Treatment Major Product Offerings
7.7.4 Astellas Pharma Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.7.5 Astellas Pharma Key News & Latest Developments
7.8 Noctrix Health
7.8.1 Noctrix Health Company Summary
7.8.2 Noctrix Health Business Overview
7.8.3 Noctrix Health Restless Legs Syndrome Treatment Major Product Offerings
7.8.4 Noctrix Health Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.8.5 Noctrix Health Key News & Latest Developments
7.9 Zhejiang Huahai
7.9.1 Zhejiang Huahai Company Summary
7.9.2 Zhejiang Huahai Business Overview
7.9.3 Zhejiang Huahai Restless Legs Syndrome Treatment Major Product Offerings
7.9.4 Zhejiang Huahai Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.9.5 Zhejiang Huahai Key News & Latest Developments
7.10 Psychocare Health
7.10.1 Psychocare Health Company Summary
7.10.2 Psychocare Health Business Overview
7.10.3 Psychocare Health Restless Legs Syndrome Treatment Major Product Offerings
7.10.4 Psychocare Health Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.10.5 Psychocare Health Key News & Latest Developments
7.11 Axxonis Pharma
7.11.1 Axxonis Pharma Company Summary
7.11.2 Axxonis Pharma Business Overview
7.11.3 Axxonis Pharma Restless Legs Syndrome Treatment Major Product Offerings
7.11.4 Axxonis Pharma Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.11.5 Axxonis Pharma Key News & Latest Developments
7.12 Jazz Pharmaceuticals
7.12.1 Jazz Pharmaceuticals Company Summary
7.12.2 Jazz Pharmaceuticals Business Overview
7.12.3 Jazz Pharmaceuticals Restless Legs Syndrome Treatment Major Product Offerings
7.12.4 Jazz Pharmaceuticals Restless Legs Syndrome Treatment Revenue in Global Market (2018-2023)
7.12.5 Jazz Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Restless Legs Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Restless Legs Syndrome Treatment Market Drivers in Global Market
Table 3. Restless Legs Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Restless Legs Syndrome Treatment in Global Market
Table 5. Top Restless Legs Syndrome Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Restless Legs Syndrome Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Restless Legs Syndrome Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Restless Legs Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Restless Legs Syndrome Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Restless Legs Syndrome Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Restless Legs Syndrome Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Restless Legs Syndrome Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Restless Legs Syndrome Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Restless Legs Syndrome Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Restless Legs Syndrome Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Restless Legs Syndrome Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Boehringer Ingelheim Company Summary
Table 31. Boehringer Ingelheim Restless Legs Syndrome Treatment Product Offerings
Table 32. Boehringer Ingelheim Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Boehringer Ingelheim Key News & Latest Developments
Table 34. Jazz Pharmaceuticals Company Summary
Table 35. Jazz Pharmaceuticals Restless Legs Syndrome Treatment Product Offerings
Table 36. Jazz Pharmaceuticals Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Jazz Pharmaceuticals Key News & Latest Developments
Table 38. GSK Plc Company Summary
Table 39. GSK Plc Restless Legs Syndrome Treatment Product Offerings
Table 40. GSK Plc Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. GSK Plc Key News & Latest Developments
Table 42. UCB Company Summary
Table 43. UCB Restless Legs Syndrome Treatment Product Offerings
Table 44. UCB Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. UCB Key News & Latest Developments
Table 46. Sun Pharmaceutical Company Summary
Table 47. Sun Pharmaceutical Restless Legs Syndrome Treatment Product Offerings
Table 48. Sun Pharmaceutical Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Sun Pharmaceutical Key News & Latest Developments
Table 50. Arbor Pharmaceuticals Company Summary
Table 51. Arbor Pharmaceuticals Restless Legs Syndrome Treatment Product Offerings
Table 52. Arbor Pharmaceuticals Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Arbor Pharmaceuticals Key News & Latest Developments
Table 54. Astellas Pharma Company Summary
Table 55. Astellas Pharma Restless Legs Syndrome Treatment Product Offerings
Table 56. Astellas Pharma Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Astellas Pharma Key News & Latest Developments
Table 58. Noctrix Health Company Summary
Table 59. Noctrix Health Restless Legs Syndrome Treatment Product Offerings
Table 60. Noctrix Health Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Noctrix Health Key News & Latest Developments
Table 62. Zhejiang Huahai Company Summary
Table 63. Zhejiang Huahai Restless Legs Syndrome Treatment Product Offerings
Table 64. Zhejiang Huahai Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Zhejiang Huahai Key News & Latest Developments
Table 66. Psychocare Health Company Summary
Table 67. Psychocare Health Restless Legs Syndrome Treatment Product Offerings
Table 68. Psychocare Health Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Psychocare Health Key News & Latest Developments
Table 70. Axxonis Pharma Company Summary
Table 71. Axxonis Pharma Restless Legs Syndrome Treatment Product Offerings
Table 72. Axxonis Pharma Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Axxonis Pharma Key News & Latest Developments
Table 74. Jazz Pharmaceuticals Company Summary
Table 75. Jazz Pharmaceuticals Restless Legs Syndrome Treatment Product Offerings
Table 76. Jazz Pharmaceuticals Restless Legs Syndrome Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. Jazz Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Restless Legs Syndrome Treatment Segment by Type in 2022
Figure 2. Restless Legs Syndrome Treatment Segment by Application in 2022
Figure 3. Global Restless Legs Syndrome Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Restless Legs Syndrome Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Restless Legs Syndrome Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Restless Legs Syndrome Treatment Revenue in 2022
Figure 8. By Type - Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 16. US Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 28. China Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Restless Legs Syndrome Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Restless Legs Syndrome Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Boehringer Ingelheim Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Jazz Pharmaceuticals Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GSK Plc Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. UCB Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sun Pharmaceutical Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Arbor Pharmaceuticals Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Astellas Pharma Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Noctrix Health Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Zhejiang Huahai Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Psychocare Health Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Axxonis Pharma Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jazz Pharmaceuticals Restless Legs Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ レストレスレッグス症候群治療の世界市場見通し2023年-2029年(Restless Legs Syndrome Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

レストレスレッグス症候群治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp